Literature DB >> 15028446

Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?

Yoshio Naya1, Alberto G Ayala, Pheroze Tamboli, R Joseph Babaian.   

Abstract

OBJECTIVES: To evaluate whether the presence of, or the number of cores containing, high-grade prostatic intraepithelial neoplasia (PIN) found in men who underwent initial extended multisite biopsy could predict which men would have prostate cancer on subsequent repeat biopsies.
METHODS: Between June 1997 and January 2003, 1086 men underwent initial prostate biopsy for early detection of prostate cancer using an extended multisite biopsy scheme. Of these, 175 men without cancer underwent at least one repeat biopsy (range one to three; median interval between biopsies, 3 months). Among these 175 patients, 47 had high-grade PIN on initial biopsy.
RESULTS: The initial extended biopsy identified cancer in 33.8% (367 of 1086) and high-grade PIN in 20.8% (226 of 1086). The incidence of high-grade PIN only in patients found to have cancer on initial biopsy was 29.7% (109 of 367). The presence of high-grade PIN was associated with concurrent prostate cancer at the initial biopsy (P <0.0001). Overall, repeat biopsy identified cancer in 18.3% of the 175 men. Of the 47 men with high-grade PIN, 5 (10.6%) were found to have cancer on repeat biopsy. The number of biopsy specimens positive for high-grade PIN on initial biopsy was not associated with the likelihood of prostate cancer on repeat biopsy. Multivariate logistic regression analysis showed that neither the presence of high-grade PIN nor the number of cores containing high-grade PIN on initial biopsy were predictors for prostate cancer on repeat biopsy.
CONCLUSIONS: The number of cores positive for high-grade PIN was not predictive for cancer on repeat biopsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028446     DOI: 10.1016/j.urology.2003.09.066

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.

Authors:  Juan-Miguel Mosquera; Sven Perner; Elizabeth M Genega; Martin Sanda; Matthias D Hofer; Kirsten D Mertz; Pamela L Paris; Jeff Simko; Tarek A Bismar; Gustavo Ayala; Rajal B Shah; Massimo Loda; Mark A Rubin
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

2.  Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

Authors:  James R Marshall; Catherine M Tangen; Wael A Sakr; David P Wood; Donna L Berry; Eric A Klein; Scott M Lippman; Howard L Parnes; David S Alberts; David F Jarrard; W Robert Lee; J Michael Gaziano; E David Crawford; Benjamin Ely; Michael Ray; Warren Davis; Lori M Minasian; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-06

Review 3.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

4.  Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation.

Authors:  Moamen M Amin; Suganthiny Jeyaganth; Nader Fahmy; Louis Bégin; Samuel Aronson; Stephen Jacobson; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

5.  High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.

Authors:  Debra L Zynger; Ximing Yang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-22

Review 6.  Dealing with non-cancerous findings on prostate biopsy.

Authors:  Timothy C Brand; Gregory P Thibault; Joseph W Basler
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 2.862

7.  Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study.

Authors:  Yi Wang; Xizhi Wang; Jiang Yu; Jun Ouyang; Weidong Shen; Yibin Zhou; Jianquan Hou; Duangai Wen; Jinxian Pu; Yuxi Shan; Boxin Xue
Journal:  J Res Med Sci       Date:  2016-09-01       Impact factor: 1.852

8.  ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients.

Authors:  Najla Aldaoud; Ashley Graboski-Bauer; Nour Abdo; Samir Al Bashir; Ashraf O Oweis; Hanadi Ebwaini; Yousef Hasen; Rami Alazab; Kiril Trpkov
Journal:  Res Rep Urol       Date:  2019-05-22

9.  Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures.

Authors:  Nagi Kumar; Theresa Crocker; Tiffany Smith; Shahnjayla Connors; Julio Pow-Sang; Philippe E Spiess; Kathleen Egan; Gwen Quinn; Michael Schell; Said Sebti; Aslam Kazi; Tian Chuang; Raoul Salup; Mohamed Helal; Gregory Zagaja; Edouard Trabulsi; Jerry McLarty; Tajammul Fazili; Christopher R Williams; Fred Schreiber; Kyle Anderson
Journal:  J Clin Trials       Date:  2012-01-21

10.  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Authors:  Nagi Kumar; Ganna Chornokur
Journal:  Transl Med (Sunnyvale)       Date:  2012-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.